PPARGC1A and pulmonary fibrosis: The activation of PGC-1α ameliorates LPS-induced mitochondrial dysfunction, suppresses the formation of mtDNA-migrasomes, inhibits the MMT process and, consequently, attenuates pulmonary fibrosis.